Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Neuromyelitis Optica With Onset in Childhood and Adolescence.
Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis.
Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system.
Caffeine and alcohol intakes have no association with risk of multiple sclerosis.
Riluzole attenuates excitatory amino acid transporter type 3 activity in Xenopus oocytes via protein kinase C inhibition.
Endovascular correction of cerebrovenous anomalies in Multiple Sclerosis: A retrospective review of an uncontrolled case series.
Development of nucleic acid drugs for neurological disorders.
Association between a Genetic Variant of Type-1 Cannabinoid Receptor and Inflammatory Neurodegeneration in Multiple Sclerosis.
Effects of cannabis on cognition in patients with MS: A psychometric and MRI study.
Neurodegeneration and Neuroprotection in Multiple Sclerosis.
Genetic characterization of gliomas arising in patients with multiple sclerosis.
Future clinical challenges in multiple sclerosis: Relevance to sphingosine 1-phosphate receptor modulator therapy.
Validation and interpretation of the Dutch version of the Multiple Sclerosis Neuropsychological Screening Questionnaire.
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies.
Animal assisted interventions in neurorehabilitation: A review of the most recent literature.
Smoking and Risk of Multiple Sclerosis: Evidence of Modification by NAT1 Variants.
Low dose naltrexone for induction of remission in Crohn's disease.
Balance exercise program reduced falls in people with multiple sclerosis - a single group pretest posttest trial.
Multiple sclerosis: The potassium channel KIR4.1-a potential autoantigen in MS.
The Spectrum of Neuromyelitis Optica (NMO) in Childhood.
Tumefactive demyelinating lesions during etanercept treatment requiring decompressive hemicraniectomy.
Analysis of CD4+CD8+ double positive T cells in blood, cerebrospinal fluid and multiple sclerosis lesions.
Transient gadolinium leakage in natalizumab-treated multiple sclerosis.
Multiple sclerosis: Five new things.
A manual of diseases of the nervous system

Pages